OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

10472	Companies
220552	Keywords
149880	Articles
116637	Press releases

Home
Companies
OXURION

BRIEF

published on 08/04/2025 at 08:35, 9 months 25 days ago

Oxurion completes acquisition of 72% of Axiodis CRO

Acquisition External Growth Clinical Data Oxurion Axiodis CRO
PRESS RELEASE

published on 08/04/2025 at 08:30, 9 months 25 days ago

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Oxurion completes the acquisition of 72% stake in Axiodis CRO, paving the way for an integrated platform focused on clinical data. Intensifies discussions with strategic targets in France and Europe

Acquisition Europe Intégration Clinical Data Oxurion
BRIEF

published on 07/30/2025 at 18:05, 9 months 30 days ago

Oxurion Receives a Modified Transparency Notification

Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/30/2025 at 18:00, 9 months 30 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification on shareholder ownership crossing under threshold due to selling of voting securities. Press release replaces previous announcement

Transparency Notification Biopharmaceutical Oxurion NV Voting Securities Shareholder Ownership
BRIEF

published on 07/25/2025 at 18:05, 10 months 4 days ago

Oxurion Announces Capital Increase via Bond Conversion

Common Shares Capital Increase Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/25/2025 at 18:00, 10 months 4 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 10 convertible bonds in Oxurion, resulting in a EUR 250,000 capital increase. Oxurion continues focus on innovative therapeutics for elderly vision preservation

Capital Increase Therapeutics Atlas Special Opportunities Oxurion Vision Preservation
BRIEF

published on 07/24/2025 at 18:05, 10 months 5 days ago

Oxurion capital increase following a bond conversion

Capital Biotechnology Actions Atlas Oxurion
PRESS RELEASE

published on 07/24/2025 at 18:00, 10 months 5 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 7 bonds in Oxurion, leading to EUR 175,000 capital increase. Oxurion focuses on therapeutic innovation to preserve elderly vision

Capital Increase Atlas Special Opportunities Oxurion Therapeutic Innovation Vision Preservation
BRIEF

published on 07/23/2025 at 18:05, 10 months 6 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/23/2025 at 18:00, 10 months 6 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding share threshold crossing under Belgian legislation

Transparency Notification Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC Share Threshold

Accesswire

Published on 05/30/2026 at 02:40, 30 minutes ago

BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 1 hour 40 minutes ago

Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 2 hours 39 minutes ago

Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 4 hours 10 minutes ago

The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
Published on 05/29/2026 at 23:00, 4 hours 10 minutes ago

IBC Advanced Alloys Reports Improved Financial Results for the Quarter Ended March 2026

View all ACCESSWIRE

EQS Group

Published on 05/29/2026 at 21:42, 5 hours 27 minutes ago

EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 5 hours 40 minutes ago

Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 20:00, 7 hours 10 minutes ago

Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 7 hours 23 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 7 hours 42 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/29/2026 at 22:00, 5 hours 10 minutes ago

Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 9 hours 10 minutes ago

Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 17:52, 9 hours 17 minutes ago

Share buyback mandate
Published on 05/29/2026 at 12:00, 15 hours 10 minutes ago

Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 16 hours 40 minutes ago

bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market

View all LES ECHOS COMFI WIRE